Skip to content

Clinical trials

Terminated Mesothelioma, Malignant trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mesothelioma, Malignant Status: Terminated Clear all

39 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20042
20051
20061
20072
20081
20091
20101
20121
20133
20154
20161
20172
20184
20193
20202
20211
20223
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated39

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)6
Verastem, Inc.3
Aduro Biotech, Inc.1
Alliance for Clinical Trials in Oncology1
Aminex Therapeutics, Inc.1
Arkadiusz Z. Dudek, MD1
Augusta University1
Burzynski Research Institute1
Capital Medical University1
Columbia University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mesothelioma, Malignant39
Carcinoma, Non-Small-Cell Lung12
Esophageal Neoplasms7
Mesothelioma6
Melanoma5
Stomach Neoplasms5
Colorectal Neoplasms4
Neoplasms4
Ovarian Neoplasms4
Sarcoma4

Trials

Showing 76 to 39 of 39. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.